2,3,7,8,-Tetrachlorodibenzo-p-dioxin (TCDD) administered in vivo causes drastic reduction in the weight of the mouse thymus at low doses (e.g., 30 pg/kg single i.p. i jection), the reduction becoming statistically significant after 2 days. To understand the cause for such thymic involution TCDD-evoked changes in various biochemical parameters in this tissue were examined. The most noticeable change was observed in the increased activity of specific protein-tyrosine kinases and protein kinase C and an increased level of p21-associated binding of [3H]GTP. Since no significant change was observed with cAMP-stimulated protein kinases and cAMP levels, the above changes appear to be a selective effect on these special classes of proteins. As a result of a time sequence study it has become apparent that the rise in proteintyrosine kinase activities becomes significant within 24 hr, whereas the rise in protein kinase C does not become sicant until 48 hr. Among protein-tyrosine kinases, pp60c-and probably pps6lskT were found to be significantly elevated by TCDD treatment. In view of similarities between TCDD and thyroid hormones in causing thymic involution, the levels of c-erb-A expression were assessed in the liver by using avian 32P-labeled v-erb-A probe and RNA transfer blot hybridization technique. The results clearly indicate that TCDD has the property to elevate levels of mRNA bearing homology to v-erb-A. Such changes in c-erb-A expression and proteintyrosine kinase occurred only in TCDD-susceptible (responsive) strains but not in tolerant (nonresponsive) strains of mice at the dose tested. Based on such observations a hypothesis has been proposed that TCDD owes its potency to its ability to stimulate the expression of one of a family of DNAs bearing homology to v-erb-A and that one of the major consequences of such an action is stimulation of various tyrosine kinases.
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2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a very toxic, teratogenic, and carcinogenic chemical (1) (2) (3) (4) . In addition to these deleterious effects, TCDD is known to cause atrophy of thymus (5, 6) in most experimental animals. Since this lesion occurs at sublethal doses of TCDD at an early stage of poisoning, it has been used by several scientists (e.g., refs. 2, 7, 8) as a sensitive indicator of TCDD poisoning.
As for the possible cause for such a thymic lesion, Neal et al. (9) have shown that an increase in serum glucocorticoid levels is unlikely. Poland and Glover (7) have found that involution of thymus occurs at low doses of TCDD (30 ,ug/ kg) in sensitive (responsive) strains of mice but only at high doses in tolerant (nonresponsive) strains of mice. These workers used such differential responses among mouse strains as a biochemical indicator for the involvement of specific cytosolic TCDD binding proteins (i.e., TCDD receptor) in the final expression of thymic involution.
Our research group has been studying the effects of TCDD on the hepatic plasma membrane receptors. To date, the plasma membrane-bound epidermal growth factor (EGF) receptor appears to be the most sensitive indicator of the effect of TCDD (10, 11) . The cause for such a change in EGF receptor in the hepatic tissue has been proposed to be an increase in intracellular protein kinases (12 Collett and Erikson (13) with a minor modification (14) . Protein Kinase Activity Assay. The activity of general protein kinases was determined as before (12) and used histone as an exogenous substrate. The assay for proteintyrosine kinase activity was basically that of Wong and Goldberg (15) as modified by Bombick and Matsumura (16) . Individual protein-tyrosine kinases were examined with a Sephadex G-150 column (14) .
Thymic membranes in homogenizing buffer were phosphorylated by using the protein-tyrosine kinase electrophoresed on a 10% NaDodSO4/polyacrylamide gel following the procedure of Laemmli (17) . The gels were dried and autoradiographed by using x-ray films. Protein kinase C activity in thymic membranes was determined according to the method originated in Y. Nishizuka's laboratory using histone as an exogenous substrate (18, 19) . A slight modification entailed solubilization of protein kinase C from thymic membranes with an EGTA/EDTA solution (20) . After centrifugation at 100,000 x g for 1 hr at 4°C the supernatant was used as the enzyme source.
GTP Binding Assay and cAMP Analysis. Membrane protein (100 ,g) in 75 ,u of homogenizing buffer was added to GTP buffer (20 mM Tris, pH 7.4/1 mM dithiothreitol/5 mM MgCl2/100 mM NaCl) containing 4 g of bovine serum albumin per 100 ml. Samples were incubated either with 100 pg of [3H]GTP (2 ,uCi; 1 Ci = 37 GBq) alone or with 100 ,ug of unlabeled GTP for nonspecific binding. After incubation for 30 min at 30°C the reaction was stopped by adding 5 ml of ice-cold GTP buffer and filtered through a 0.45-,um HAWP Millipore filter. An additional 5-ml aliquot of ice-cold GTP buffer was passed through the filter. The filter was dried and assayed for radioactivity on a scintillation counter. Specific GTP binding was calculated by subtracting the nonspecific binding from total binding. Determination of cAMP levels was made in thymic homogenates prior to centrifugation. The assay was described by Amersham, the producer of the particular RIA kit utilized in this study.
Determination of p21r, -GTP Binding. Membrane protein (500 ,g) in 50 1.l of homogenizing buffer was added to 50 ,ul of GTP buffer containing 2 ,uCi of [3H]GTP (100 pg). After 30 min at 30°C the membranes were solubilized by adding 50 ,ul of a 1:1 solution of 7 M guanidine'HCI/GTP buffer. The mixture was diluted with 10 vol of GTP buffer, and 10 A1 of the p2lras antibody (polyclonal sheep antibody to both Ha-ras and Ki-ras; Triton Bioscience, Houston, TX) was added, dispersed in a Vortex, and incubated for 2 hr at 4°C. A rabbit anti-sheep IgG antibody (10 ,ul; U.S. Biochemical, Cleveland, OH) was added and incubated for another hour at 4°C. A suspension of protein A-Sepharose CL-4B (12.5 mg in 100 ,ul of GTP buffer) was added; this was followed by frequent mixing for 30 min at 4°C and centrifugation for 2 min on an Eppendorf centrifuge as before. The p2lras immunocomplex was washed twice with 400 ,ul of GTP buffer. The p2lras immunocomplex was removed from the Sepharose by addition of 200 ,u1 of electrophoresis treatment buffer and heated as before. Aliquots of the supernatant were then assayed for radioactivity in a scintillation counter. The background values were obtained by carrying out the identical experiment without the p2lras antibody for each run and were subtracted from the experimental values. To determine the molecular mass of p2lras, 3H-labeled proteins were isolated (as above) and were analyzed on Sephadex G-50 calibrated with standard proteins. The radioactivity found in the 21-kDa fraction was 57.2% (control) to 60.8% (treated) of the total proteinbound radioactivities.
Preparation of DNA Probe and RNA Transfer Blot Hybridization. The avian AEV-10 2.5-kilobase (kb) Pvu II fragment was kindly provided by H. J. Kung. It is cloned into the Pvu II site of pBR322 plasmid in Escherichia coli (21) . The Pst I fragment (0.5 kb) was obtained from isolated plasmids through restriction analysis, agarose gel electrophoresis, and electroeluting. 32P nick-translation labeling was carried out (22) by using [a-32P]dCTP from New England Nuclear, and the resulting labeled DNA was used for dot hybridization according to the method of Winberry et al. (23) . The total RNA was isolated from individual livers by the method of Chirgwin et al. (24) . Two hundred micrograms of RNA was used per assay. The above experiment was repeated once more with v-erb-A probe purchased from Oncor. After hybridization, washed and dried discs were radioassayed for radioactivity. The purity of both probes was ascertained by using agarose gel electrophoresis with subsequent blotting to nitrocellulose sheets (21) and autoradiography.
RESULTS
In view of the clear-cut difference in sensitivity toward TCDD among mouse strains (7, 8) we first surveyed the in vivo effects of various chemical agents on thymic weights in a susceptible strain, C57BL/6J, and a tolerant strain, DBA/2J. TCDD caused a dose-dependent thymic involution in the C57BL/6J strain by day 2, whereas such an effect was only evident at the highest dose tested in the tolerant strain (Table 1) . Such a differential effect was observed not only with a high dose of 3-methylcholanthrene as previously shown (7, 8) (Tables 2 and 3 ).
An examination of the time sequence of TCDD-caused changes in these protein kinase activities revealed that the change in protein-tyrosine kinase precedes that of protein kinase C, the former event occurring as early as 12 hr after TCDD administration (Fig. 1) . To confirm that the TCDDcaused change in thymic protein kinase activities involves activation of some protein-tyrosine kinase, the total membranes phosphorylated with ['y-32P]ATP without angiotensin were digested with strong acid, and the resulting phosphoamino acids were analyzed by TLC (25) . The extent of labeling at the tyrosine residue was (31% ± 17%, mean + SD, four animals each) higher in the preparation from the treated animals (C57BL/6J, 115 ,ug/kg, analyzed after 48 hr) than that from the control animals.
To study the nature of protein-tyrosine kinase changes, the total membranes from the thymus of control and treated animals (obtained 12 hr after treatments) were dissolved with a detergent and subjected to Sephadex G-150 column separation, and protein-tyrosine kinase activity of each fraction was measured. The effect of TCDD treatment in this regard was most significant in the protein fractions with molecular mass ranges of about 50-60 and 70-80 kDa (Fig. 2 ). An electrophoresis examination of the [32P]phosphoproteins resulting from incubation of total thymic membranes with [_y-32P]ATP (Fig. 3) (26-28). When this agent was coinjected at 50 mg/kg with TCDD, the effects of the latter compound on the thymic weight could be reversed (Table 4) . At the same time the portion of the protein-tyrosine kinase activity that was elevated by TCDD was reduced by the coinjected quercetin. We also examined the effects of various agents on thymic weights and protein-tyrosine kinase activities (Table 5) . At certain doses 17p-estradiol and dexamethasone were found to reduce thymic weights and elevate protein-tyrosine kinase activities. Phenobarbital did not cause stimulation ofproteintyrosine kinase even at 50 mg/kg.
The above observations raise a natural question whether there is a common denominator among the agents that cause thymic weight reduction and alteration of the levels of protein-tyrosine kinases. One important clue is the difference in responsiveness to TCDD among various mouse strains (Table 1) . To examine the extent of parallelism between their responsiveness to TCDD vs. that to other agents, T3 was injected into various strains, and its effects on the thymic weight were monitored. The results ( Table 6 ) clearly indicate that the parallelism is a perfect one among all strains tested. It has been recently shown that DNAs encoding receptors for estradiol (28) (29) (30) , steroid hormones (30, 31) , and thyroid hormones (32, 33) bear extensive homology to v-erb-A, an oncogene of avian erythroblastosis virus (33, 34) . To test the hypothesis that the common denominator of these agents including TCDD is to increase the expression of c-erb-A, the level of specific TCDD-stimulated mRNAs was assessed by RNA transfer blot hybridization with 32P-labeled v-erb-A DNA probe and total RNA extracts from treated and control mice. TCDD has the property of increasing c-erb-A expression in the responsive mice but not in the nonresponsive ones at the time-dose regimen tested (Table 7) .
DISCUSSION
We have found that thymic involution in mice can be caused by a variety of agents other than TCDD, 3-methylcholanthrene, and dexamethasone as reported (see ref.
2). Of those agents, thyroxine derivatives and estradiol are of great interest, since there is a clear-cut interstrain difference between TCDD-responsive and TCDD-nonresponsive strains in their susceptibilities toward these agents.
Such an observation supports the view that TCDD receptor belongs to the family of c-erb-A products and that a mutation on the c-erb-A DNA in these nonresponsive mice makes them less responsive to all of these agents, whose actions are mediated through c-erb-A expressions. Perhaps the most pertinent observation to the understanding of the above hypothesis is that v-erb-A, when introduced to cultured erythroid cells in vitro by way of DNA transformation, has been shown to cooperate with the expression of src, seafps, erb-B, and Ha-ras (35) . The latter oncogenes are showed the property of increasing the levels of p2l's, p60src, and probably p56lskT in the mouse thymus. Among c-erb-Arelated agents tested in this work T3 appears to be closest to TCDD in its ability to affect thymic weight. In fact, the dose-time range of the former to cause thymic involution is no different from the latter in this species. Thyroid hormones are also known to modulate protein-tyrosine kinases (37, 38) . It is possible that in this species T3 and TCDD act on the same receptor.
One may ask: What is the relationship between TCDDinduced thymic atrophy and changes in protein-tyrosine kinase activities? The general relevance of these two phenomena may be inferred, since quercetin, which is known to inhibit certain protein-tyrosine kinases in vitro, has been shown to prevent TCDD from causing thymic involution in vivo. In agreement with an earlier observation in the liver (39) , the most conspicuous change is in protein-tyrosine kinase activities in the molecular mass range of 50-60 kDa. One of the protein kinases whose activity is stimulated is pp60src protein. Unfortunately, the role of pp6Osrc in thymus is not well known. As to the nature of56-kDa protein-tyrosine kinase there are a number of reports indicating that it is of lymphocyte origin (39) (40) (41) (42) (43) (44) (45) . That activation ofprotein kinases associated with lymphocytes is in some way related to maturation of lymphocytes has been considered by several groups (40) (41) (42) (43) (44) (45) (46) . The oncogenic property of the viral gene encoding p56 has been recognized and two designations, lskT (46) and tck (see ref. 47) , have been assigned. Marth et al. (46) speculate that, if p56 tyrosine kinase activity is associated with T-cell blastogenesis, a functional role for pp56 might reside in transducing mitogenic signals from lymphocytespecific receptors such as those for interleukin 2. Another supporting fact is that such a change in proteintyrosine kinases is accompanied by an increase in p2lras protein, indicating an activation of c-ras, which appears to have the property of being activated whenever one or more protein-tyrosine kinases are activated (48) .
Further research is needed to answer these questions. The phenomenon of activation of c-erb-A expression and proteintyrosine kinases by TCDD alone appears to merit close attention in view of the recent realization of the importance of these biochemical pathways in cellular modulation and the extreme toxicities of TCDD itself.
